<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582175</url>
  </required_header>
  <id_info>
    <org_study_id>Uoradea</org_study_id>
    <nct_id>NCT04582175</nct_id>
  </id_info>
  <brief_title>Comparison Between Two Revascularization Strategies in MVD Patients With Uncomplicated ST-elevation MI</brief_title>
  <acronym>Promise</acronym>
  <official_title>A Retrospective, One Center Comparison of Outcomes Between Complete Revascularization by PCI at the Time of PPCI or During the Index Hospital Admission in One Hundred MVD Patients With ST-elevation MI Uncomplicated by Cardiogenic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oradea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oradea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to compare major adverse cardiac and cerebrovascular events(MACCE) and&#xD;
      mortality at one year between two strategies: complete revascularization including&#xD;
      non-culprit lesions percutaneous coronary intervention(PCI) during primary PCI(PPCI) versus&#xD;
      complete revascularisation during the same hospital admission in multi-vascular coronary&#xD;
      artery disease(MVD) patients presenting with ST-elevation myocardial infarction(STEMI)&#xD;
      uncomplicated by cardiogenic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Complete revascularisation in MVD patients with STEMI uncomplicated by cardiogenic shock has&#xD;
      been shown to improve outcomes, however the optimal timing of treatment of the non-culprit&#xD;
      lesions is not known. The 2018 ESC/EACTS Guidelines on myocardial revascularization states&#xD;
      that &quot;routine revascularization of non-IRA (infarct related artery) lesions should be&#xD;
      considered in patients with multivessel disease before hospital discharge&quot;. Our trial showed&#xD;
      that among the fore mentioned patients there was no difference regarding outcomes when using&#xD;
      a strategy of complete revascularization with non-culprit lesions PCI during PPCI or during&#xD;
      the same hospital admission.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">September 5, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>one year all-cause mortality</measure>
    <time_frame>one year</time_frame>
    <description>death at one year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACCE at one year</measure>
    <time_frame>one year</time_frame>
    <description>major adverse cardiac and cerebrovascular events including cardiac death, stroke, symptom-driven revascularization, myocardial infarction</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <description>patients who received complete revascularization by angioplasty during the PPCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>patients who underwent complete revascularization by angioplasty in a staged procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>angioplasty</intervention_name>
    <description>angioplasty of all non-culprit lesions</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>group A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        multivessel patients with STEMI uncomplicated by cardiogenic shock&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women with successful PCI (preferably using a drug-eluting stent) to the&#xD;
             culprit lesion for STEMI ( PCI for STEMI should be primary PCI in the first 12 hours&#xD;
             after symptom onset) and complete revascularization of non-culprit lesions during the&#xD;
             index PPCI procedure or during a different procedure performed before index hospital&#xD;
             discharge.&#xD;
&#xD;
          2. Multi-vessel disease defined as at least 1 additional non-infarct related coronary&#xD;
             artery lesion that is at least 2.5 mm in diameter that has not been stented as part of&#xD;
             the primary PCI and that is amenable to successful treatment with PCI and has:&#xD;
&#xD;
               -  At least 75% diameter stenosis (visual estimation) or&#xD;
&#xD;
               -  At least 50% diameter stenosis (visual estimation) with fractional flow reserve&#xD;
                  (FFR) â‰¤ 0.80&#xD;
&#xD;
          3. Age between 18 and 90 years&#xD;
&#xD;
          4. Written informed consent could be obtained from all the patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Rescue PCI for failed fibrinolysis or a combination strategy where PCI is performed&#xD;
             routinely 3-12 hours after fibrinolysis&#xD;
&#xD;
          2. Cardiogenic shock&#xD;
&#xD;
          3. Non-cardiovascular known co-morbidity reducing life expectancy to &lt; 2 years&#xD;
&#xD;
          4. Any factor precluding 1year follow-up&#xD;
&#xD;
          5. Prior Coronary Artery Bypass Graft (CABG) Surgery&#xD;
&#xD;
          6. A different operator from the previously designated&#xD;
&#xD;
          7. Unable to provide consent for any other reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mihnea-Traian T Nichita-Brendea, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spitalul Clinic Judetean de Urgenta Oradea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta Oradea</name>
      <address>
        <city>Oradea</city>
        <state>Bihor</state>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 4, 2020</study_first_submitted>
  <study_first_submitted_qc>October 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 8, 2020</last_update_submitted>
  <last_update_submitted_qc>October 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oradea</investigator_affiliation>
    <investigator_full_name>Nichita-Brendea Mihnea-Traian</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>PPCI, multivessel coronary artery disease, STEMI</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

